Patent · US Active

Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds

US9676783B2 · kind B2 · utility

22Cited by

10References

83Claims

0Family size

Assignee

Array BioPharma, Inc. · US

Inventors

Julia Haas · Boulder, US
Steven W. Andrews · Longmont, US
Yutong Jiang · Boulder, US
Gan Zhang · Boulder, US

Key dates

Filing date	Sep 4, 2015
Grant date	Jun 13, 2017
Priority date	—
Expiry date	Sep 4, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.